Literature DB >> 1457521

Cisplatin and platinum analogues: recent advances.

R J Fram1.   

Abstract

Cisplatin is a critically important antineoplastic agent employed in treating patients who have a broad spectrum of neoplasms. Resistance to this agent poses a serious clinical dilemma. The objective of this review is to summarize the principal mechanisms that contribute to cytotoxicity by this agent and underlie resistance. Knowledge of these processes provides a rational basis for developing therapeutic strategies to circumvent resistance.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1457521     DOI： 10.1097/00001622-199212000-00012

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN： 1040-8746            Impact factor:   3.645


  15 in total

1.  Activity and DNA binding of new organoamidoplatinum (II) complexes.

Authors:  T Talarico; D R Phillips; G B Deacon; S Rainone; L K Webster
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  Recognition of DNA alterations by the mismatch repair system.

Authors:  G Marra; P Schär
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

3.  Hyperthermia generated with ferucarbotran (Resovist®) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells.

Authors:  Itaru Sato; Masanari Umemura; Kenji Mitsudo; Mitomu Kioi; Hideyuki Nakashima; Toshinori Iwai; Xianfeng Feng; Kayoko Oda; Akiyoshi Miyajima; Ayako Makino; Maki Iwai; Takayuki Fujita; Utako Yokoyama; Satoshi Okumura; Motohiko Sato; Haruki Eguchi; Iwai Tohnai; Yoshihiro Ishikawa
Journal:  J Physiol Sci       Date:  2014-03-12       Impact factor: 2.781

4.  Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin.

Authors:  Robert F Murphy; Edina Komlodi-Pasztor; Robert Robey; Frank M Balis; Nicholas P Farrell; Tito Fojo
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

5.  Kaempferol suppresses cisplatin-induced apoptosis via inductions of heme oxygenase-1 and glutamate-cysteine ligase catalytic subunit in HEI-OC1 cell.

Authors:  Shang Shang Gao; Byung-Min Choi; Xiao Yan Chen; Ri Zhe Zhu; Youngho Kim; HongSeob So; Raekil Park; Meesook Sung; Bok-Ryang Kim
Journal:  Pharm Res       Date:  2010-02       Impact factor: 4.200

6.  Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1.

Authors:  HongSeob So; HyungJin Kim; Yunha Kim; Eunsook Kim; Hyun-Ock Pae; Hun-Taeg Chung; Hye-Jung Kim; Kang-Beom Kwon; Kang-Min Lee; Haa-Yung Lee; Sung-Kyun Moon; Raekil Park
Journal:  J Assoc Res Otolaryngol       Date:  2008-06-27

7.  Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB.

Authors:  Hongseob So; HyungJin Kim; Jeong-Han Lee; Channy Park; Yunha Kim; Eunsook Kim; Jin-Kyung Kim; Ki-Jung Yun; Kang-Min Lee; Haa-Yung Lee; Sung-Kyun Moon; David J Lim; Raekil Park
Journal:  J Assoc Res Otolaryngol       Date:  2007-05-22

8.  Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.

Authors:  Kyung Hee Lee; Myung Soo Hyun; Hoon-Kyo Kim; Hyung Min Jin; Jinmo Yang; Hong Suk Song; Young Rok Do; Hun Mo Ryoo; Joo Seop Chung; Dae Young Zang; Ho-Yeong Lim; Jong Youl Jin; Chang Yeol Yim; Hee Sook Park; Jun Suk Kim; Chang Hak Sohn; Soon Nam Lee
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

9.  Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein.

Authors:  Cheol-Hee Choi; Yoon-Jung Cha; Chun-San An; Kyung-Jong Kim; Kweon-Cheon Kim; Sung-Pyo Moon; Zang Hee Lee; Young-Don Min
Journal:  Cancer Cell Int       Date:  2004-10-19       Impact factor: 5.722

10.  Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice.

Authors:  Hao Pan; Kezhen Shen; Xueping Wang; Hongzhou Meng; Chaojun Wang; Baiye Jin
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.